Premier Biomedical, Inc.
BIEI
Rank in Stocks
#32669
Premier Biomedical, Inc., a research-based company, discovers and develops... Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil capsule, and pet product; sequential-dialysis technique for cancer, Alzheimer’s disease, ALS, blood sepsis, leukemia, and other life-threatening cancers; and Feldetrex drug candidate for the treatment of multiple sclerosis, fibromyalgia, neuropathic pain, and traumatic brain injuries. Premier Biomedical, Inc. was founded in 2010 and is headquartered in Jackson Center, Pennsylvania.
Share Price
$0.0008
Last synced: 2026-11-09
Market Cap
$1.32M
Change (1 day)
14.29%
Change (1 year)
33.33%
Country
Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Trade Premier Biomedical, Inc. (BIEI)
Category
Healthcare
Operating Margin for Premier Biomedical, Inc. (BIEI)
Operating Margin as of November 2026 TTM: -90.00%
According to Premier Biomedical, Inc.'s latest financial reports, its current operating margin (TTM) is -90.00%. At the end of 2025 the company had an operating margin of 0.00%.
Operating Margin history for Premier Biomedical, Inc. from 2010 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -90.00% | 0.00% |
| 2025 | 0.00% | 0.00% |
| 2024 | 0.00% | 0.00% |
| 2023 | 0.00% | 0.00% |
| 2022 | 0.00% | 0.00% |
| 2021 | 0.00% | -100.00% |
| 2020 | -9,904.81% | 332.57% |
| 2019 | -2,289.76% | 31.49% |
| 2018 | -1,741.42% | -46.33% |
| 2017 | -3,244.39% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
| 2011 | 0.00% | 0.00% |
| 2010 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 62.34% | -100.69% |
US
|
|
| 31.60% | -100.35% |
SE
|
|
| 30.13% | -100.33% |
FR
|
|
| 29.76% | -100.33% |
HK
|
|
| 30.46% | -100.34% |
IT
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Premier Biomedical, Inc.'s operating margin
What is Premier Biomedical, Inc.'s operating margin?
Premier Biomedical, Inc.'s operating margin is -90.00%, as of Nov 2026.
What was Premier Biomedical, Inc.'s operating margin in 2025?
In 2025, Premier Biomedical, Inc.'s operating margin was 0.00%, compared with 0.00% in 2024.
How has Premier Biomedical, Inc.'s operating margin changed since 2020?
From 2020 to 2025, Premier Biomedical, Inc.'s operating margin was highest in 2025 (0.00%) and lowest in 2020 (-9,904.81%).
How does Premier Biomedical, Inc.'s operating margin compare with similar companies?
Premier Biomedical, Inc.'s operating margin (-90.00%) is lower than that of all 5 similar companies listed above. The highest among them is Royalty Pharma plc, with 62.34%.